发明名称 Tamper resistant transdermal dosage form
摘要 The invention comprises a transdermal dosage form comprising an active agent component comprising an active agent and an adverse agent component comprising an adverse agent, wherein the active agent component defines at least one channel extending substantially there through.
申请公布号 US8778382(B2) 申请公布日期 2014.07.15
申请号 US200410835535 申请日期 2004.04.30
申请人 Purdue Pharma L.P. 发明人 Howard Stephen A.;Reidenberg Bruce
分类号 A61K9/00;A61F2/00 主分类号 A61K9/00
代理机构 Sterne, Kessler, Goldstein & Fox P.L.L.C. 代理人 Sterne, Kessler, Goldstein & Fox P.L.L.C.
主权项 1. A transdermal dosage form comprising: an active agent component having a proximal, skin contacting surface and a distal surface and comprising an opioid agonist; an adverse agent component having a proximal surface and a distal surface and comprising an opioid antagonist; a backing; a barrier having a proximal surface and a distal surface that is interposed between the active agent component and the adverse agent component, wherein one or more channels extend completely from the proximal surface of the active agent component to the distal surface of the barrier and terminate prior to the proximal surface of the adverse agent component; wherein air is disposed in one or more channels; and wherein the barrier is permeable to a solvent selected from the group consisting of water, ethanol, ether, and mixtures thereof, and wherein the barrier is impermeable to diffusion of opioid agonist and opioid antagonist in the absence of said solvent.
地址 Stamford CT US